U.S. flag

An official website of the United States government

GRCh37/hg19 8p23.3-22(chr8:158049-18936715)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 26, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002472557.1

Allele description [Variation Report for GRCh37/hg19 8p23.3-22(chr8:158049-18936715)x1]

GRCh37/hg19 8p23.3-22(chr8:158049-18936715)x1

Genes:
Variant type:
copy number loss
Cytogenetic location:
8p23.3-22
Genomic location:
Chr8: 158049 - 18936715 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 8p23.3-22(chr8:158049-18936715)x1
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV002772425Quest Diagnostics Nichols Institute San Juan Capistrano
    criteria provided, single submitter

    (ACMG/ClinGen CNV Guidelines, 2019)
    Pathogenic
    (Aug 26, 2021)
    unknownclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

    Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

    Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230.

    PubMed [citation]
    PMID:
    31690835
    PMCID:
    PMC7313390

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002772425.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)

    Description

    The copy number loss of 8p23.3p22 involves multiple protein coding genes, including CLN8 (OMIM 607837), ARHGEF10 (OMIM 608136), CSMD1 (OMIM 608397), DLGAP2 (OMIM 605438), and GATA4 (OMIM 600576), and is expected to cause phenotypic and/or developmental abnormalities. Patients with comparable or smaller deletions of this region have a variable phenotype, including developmental delay and/or intellectual disability, neurobehavioral disorders, and craniofacial abnormalities. Congenital anomalies, such as heart defects and diaphragmatic hernia, were also reported in some patients (Shi 2017; Burnside 2013; Chien 2010; Kumar 2018). In particular, Perez et al reported a 15 Mb deletion at this locus in a fetus with increased nuchal translucency and diaphragmatic hernia (Perez 2018). A 13.32 Mb deletion of this locus was also reported in a patient with pulmonary stenosis, aortic stenosis, large ventricular septal defect, mild arch hypoplasia, bicuspid aortic valve and intrauterine growth restriction (Lazier 2016). Shi et al proposed that DLGAP2, CLN8, ARHGEF10 and CSMD1 are candidate genes for the deletion phenotype, and haploinsufficiency of GATA4 is associated with multiple cardiac diseases including atrial septal defect 2 (OMIM 607941). This large deletion also includes a few genes that are associated with OMIM phenotypes: ANGPT2 (OMIM 619369), RP1L1 (OMIM 613587 and 618826), BLK (OMIM 613375), CTSB (OMIM 148370), MCPH1 (OMIM 251200), FDFT1 (OMIM 618156 ), ASAH1 (OMIM 228000 and 159950), TUSC3 (OMIM 611093), and VPS37A (OMIM 614898). Reference Burnside et al. Am J Med Genet A. 2013 Apr;161A(4):822-8. PMID: 23495222. Chien et al. Clin Genet. 2010 Nov;78(5):449-56. PMID: 20236125. Kumar et al., J Pediatr Genet. 2018 Sep;7(3):125-129. PMID: 30105121. Lazier et al., J Obstet Gynaecol Can. 2016 Jul;38(7):619-26. PMID: 27591345. Maccarini et al., Mol Cytogenet. 2020 Jun 22;13:23. PMID: 32582378. Perez et al., Gynecol Obstet (Sunnyvale) 2018, 8:7 DOI: 10.4172/2161-0932.1000479. Shi et al. Mol Med Rep. 2017 Nov;16(5):6837-6845. PMID: 28901431. Tannour-Louet et al., Nat Med. 2014 Jul;20(7):715-24. PMID: 24880616.

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Mar 26, 2023